IFN-γ release assay conversions and reversions: Challenges with serial testing in u.s. health care workers

Annals of the American Thoracic Society

Volumn 11, Issue 3, 2014, Pages 296-302

  Joshi, Manish ^a   Monson, Thomas P ^b   Joshi, Anita ^c   Woods, Gail L ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Health care workers; IFN release assays; QuantiFERON TB gold in tube assay (QFT GIT); Tuberculosis

Indexed keywords

ADULT; ARTICLE; EMPLOYEE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN EXPERIMENT; INTERFERON GAMMA RELEASE ASSAY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS TEST KIT; REPEAT PROCEDURE; REPRODUCIBILITY; SCREENING TEST; TERTIARY CARE CENTER; UNITED STATES; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; RETROSPECTIVE STUDY; TIME; TUBERCULOSIS;

ADULT; FEMALE; HEALTH PERSONNEL; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS; UNITED STATES;

EID: 84898715886     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201310-378OC     Document Type: Article

References (23)

1. Jensen PA, Lambert LA, Iademarco MF, Ridzon R; Centers for Disease Control and Prevention (CDC). Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54:1-141.
2. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59:1-25.
3. Joshi M, Monson T, Woods G. Practical experience with the QFT assay for LTBI annual testing among US health-care workers in a large tertiary setting [abstract]. Chest 2010;138:746A.
4. Joshi M, Monson TP, Woods GL. Use of interferon-γ release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J 2012;19:84-88.
5. Cellestis. QuantiFERON-TB gold in-tube package insert [accessed 15 Jun 2013]. Available from: http://www.cellestis.com/IRM/content/PI/us.pdf
6. Zwerling A, Benedetti A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Menzies D, Pai M. Repeat IGRA testing in Canadian health workers: conversions or unexplained variability? PLoS One 2013;8:e54748.
7. Fong KS, Tomford JW, Teixeira L, Fraser TG, van Duin D, Yen-Lieberman B, Gordon SM, Miranda C. Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program. Chest 2012;142:55-62.
8. Gandra S, Scott WS, Somaraju V, Wang H, Wilton S, Feigenbaum M. Questionable effectiveness of the QuantiFERON-TB gold test (Cellestis) as a screening tool in healthcare workers. Infect Control Hosp Epidemiol 2010;31:1279-1285.
9. Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, Yoo CG, Kim YW, Han SK, Yim JJ. Monthly follow-ups of interferon-γ release assays among health-care workers in contact with patients with TB. Chest 2012;142:1461-1468.
10. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Mwansa-Kambafwile J, Fielding K, Wilkinson RJ, Pai M. Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:45-55.
11. Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlösser S, Schultze-Werninghaus G, Rohde G. Within-subject variability of Mycobacterium tuberculosis-specific γ interferon responses in German health care workers. Clin Vaccine Immunol 2011;18:1176-1182.
12. Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA. Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med 2013;187:206-211.
13. Whitworth WC, Hamilton LR, Goodwin DJ, Barrera C, West KB, Racster L, Daniels LJ, Chuke SO, Campbell BH, Bohanon J, et al. Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests. PLoS One 2012;7:e43790.
14. Herrera V, Perry S, Parsonnet J, Banaei N. Clinical application and limitations of interferon-γ release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis 2011;52:1031-1037.
15. Mancuso JD, Bernardo J, Mazurek GH. The elusive "gold" standard for detecting Mycobacterium tuberculosis infection. Am J Respir Crit Care Med 2013;187:122-124.
16. Doberne D, Gaur RL, Banaei N. Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. J Clin Microbiol 2011;49:3061-3064.
17. Slater M, Parsonnet J, Banaei N. Investigation of false-positive results given by the QuantiFERON-TB gold in-tube assay. J Clin Microbiol 2012;50:3105-3107.
18. Pai M, Elwood K. Interferon-γ release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges. Can Respir J 2012;19:81-83.
19. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-γ release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012;67:62-70.
20. Ringshausen FC, Schablon A, Nienhaus A. Interferon-γ release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol 2012;7:6.
21. Denkinger CM, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 2011;17:806-814.
22. Slater ML, Welland G, Pai M, Parsonnet J, Banaei N. Challenges with QuantiFERON-TB gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med 2013;188:1005-1010.
23. Pollock NR, McAdam AJ, Pai M, Nardell EA, Bernardo J, Banaei N, Mobo J. Interferon γ-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons. Clin Chem 2013;60:5.